(Q46221174)

20 December 2017

title

Production and use of HIV-1 luciferase reporter viruses (English)

1 reference

20 December 2017

author name string

Carsten Münk

series ordinal

1

1 reference

20 December 2017

Nathaniel R Landau

series ordinal

2

1 reference

20 December 2017

publication date

1 November 2003

1 reference

20 December 2017

Current protocols in pharmacology

published in

1 reference

20 December 2017

volume

Chapter 12

1 reference

20 December 2017

page(s)

Unit12.5

1 reference

20 December 2017

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

cites work

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

A new technique for the assay of infectivity of human adenovirus 5 DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

A block to human immunodeficiency virus type 1 assembly in murine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Use of a green fluorescent protein as a marker for human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Use of cis- and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

Combinatorial synthesis of CCR5 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH1205S22

10.1002/0471141755.PH1205S22

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017